Detalhe da pesquisa
1.
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.
Haematologica
; 108(10): 2616-2625, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051756
2.
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine.
Haematologica
; 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105738
3.
Cytomegalovirus Immune reconstitution in cord blood transplant recipients on letermovir prophylaxis.
Transpl Infect Dis
; 25(5): e14104, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37436771
4.
A Case of Fetal-Induced Graft-versus-Host Disease.
N Engl J Med
; 389(7): 668-670, 2023 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37585636
5.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica
; 106(6): 1599-1607, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499241
6.
Blood type change identifies late dominance reversal of chimerism after double umbilical cord blood transplantation with review of the literature.
Transfusion
; 61(3): 960-967, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638187
7.
Hypomethylating agents with venetoclax: have we discovered the holy grail?
Curr Opin Hematol
; 27(2): 76-80, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31895103
8.
Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
Biol Blood Marrow Transplant
; 25(10): 2091-2097, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31255741
9.
Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison.
Biol Blood Marrow Transplant
; 24(8): 1671-1677, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684565
10.
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
J Biol Chem
; 291(42): 21984-22000, 2016 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573247
11.
De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue.
FASEB J
; 30(3): 1096-108, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26581599
12.
Programmed Death 1 Expression on CD4+ T Cells Predicts Mortality after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(12): 2172-2179, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27519280
13.
PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.
N Engl J Med
; 377(1): 89-91, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28679093
14.
Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.
Haematologica
; 99(8): 1277-84, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082785
15.
Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients.
Blood
; 118(20): 5689-96, 2011 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21937692
16.
Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse.
Bone Marrow Transplant
; 58(8): 849-854, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185614
17.
Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.
J Biol Chem
; 291(48): 25280, 2016 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27888238
18.
Stable long-term pulmonary function after myeloablative double cord blood transplant.
Biol Blood Marrow Transplant
; 18(2): 309-13, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21840290
19.
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.
Blood
; 115(4): 757-65, 2010 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19822900
20.
Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.
Blood
; 116(22): 4693-9, 2010 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20686119